Investing Profile

Sanjay Mistry

InvestorVC
Vice President Venture Investments - Johnson & Johnson Innovation – JJDC Inc. at Johnson & Johnson
Photo of Sanjay Mistry, Vice President at Johnson & Johnson Innovation

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stromedix Inc. Network
267 CONNECTIONS
Stromedix Inc. Network
267 CONNECTIONS
Johnson & Johnson Network
72 CONNECTIONS
Johnson & Johnson Network
72 CONNECTIONS
Johnson & Johnson Network
72 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Rapport Therapeutics
Series BAug 2023$150M
Series AMar 2023$100M
$250M
Co-investors: Steve Paul (Third Rock Ventures), Reid Huber (Third Rock Ventures), James Healy (Financial Services, Financial Technology, and Business Services)
Postdoctoral Fellow UPMCPresent
Postdoctoral Fellow Scripps ResearchPresent
Development Scientist Stromedix Inc.Present
Assistant Director Johnson & JohnsonPresent
Vice President Lubert Adler PartnersPresent
Head of External Value Creation & Business Operations/Venture Leader Johnson & JohnsonPresent
Senior Finance Director Business Operations for Janssen Pharmaceuticals R&D Johnson & JohnsonPresent
Head JLABS @ San Diego, Johnson & Johnson Innovation Johnson & JohnsonPresent
Vice President Venture Investments - Johnson & Johnson Innovation – JJDC Inc. Johnson & JohnsonPresent
Board Observer Manifest TechnologiesPresent
Director Board of Directors Rapport TherapeuticsPresent
Director Board of Directors TRexBioPresent
Director Board of Directors Stromedix Inc.Present
Board Observer Abdera TherapeuticsPresent
Nottingham Bachelor’s Degree Bachelors of Biomedical Science/Pharmacology
University of Aberdeen Doctor of Philosophy (Ph.D.) Pharmacology
Sign in with Google →
Sign in with Google →